ML-226 |
An inhibitor of ABHD11 (IC50s = 15 and 0.68 nM, respectively, in vitro and… |
5 mg |
25681-5 |
More Info
|
ML-228 |
An activator of the HIF signaling pathway, as demonstrated by HRE reporter… |
1 mg |
14568-1 |
More Info
|
ML-228 |
An activator of the HIF signaling pathway, as demonstrated by HRE reporter… |
10 mg |
14568-10 |
More Info
|
ML-228 |
An activator of the HIF signaling pathway, as demonstrated by HRE reporter… |
5 mg |
14568-5 |
More Info
|
ML-228 |
An activator of the HIF signaling pathway, as demonstrated by HRE reporter… |
50 mg |
14568-50 |
More Info
|
ML-230 |
An inhibitor of ABCG2; selectively inhibits JC-1 efflux in Ig-MXP3 cells o… |
1 mg |
32552-1 |
More Info
|
ML-230 |
An inhibitor of ABCG2; selectively inhibits JC-1 efflux in Ig-MXP3 cells o… |
10 mg |
32552-10 |
More Info
|
ML-230 |
An inhibitor of ABCG2; selectively inhibits JC-1 efflux in Ig-MXP3 cells o… |
5 mg |
32552-5 |
More Info
|
ML-233 |
A novel apelin receptor agonist (EC50 = 3.7 µM) that is >21-fold sel… |
1 mg |
15187-1 |
More Info
|
ML-233 |
A novel apelin receptor agonist (EC50 = 3.7 µM) that is >21-fold sel… |
10 mg |
15187-10 |
More Info
|
ML-233 |
A novel apelin receptor agonist (EC50 = 3.7 µM) that is >21-fold sel… |
25 mg |
15187-25 |
More Info
|
ML-233 |
A novel apelin receptor agonist (EC50 = 3.7 µM) that is >21-fold sel… |
5 mg |
15187-5 |
More Info
|
ML-239 |
An inhibitor of cancer stem cells, displaying greater than 23-fold selecti… |
1 mg |
15188-1 |
More Info
|
ML-239 |
An inhibitor of cancer stem cells, displaying greater than 23-fold selecti… |
10 mg |
15188-10 |
More Info
|
ML-239 |
An inhibitor of cancer stem cells, displaying greater than 23-fold selecti… |
25 mg |
15188-25 |
More Info
|
ML-239 |
An inhibitor of cancer stem cells, displaying greater than 23-fold selecti… |
5 mg |
15188-5 |
More Info
|
ML-240 |
An ATP-competitive inhibitor of the D2 domain of the p97 ATPase (IC50 = 0.… |
1 mg |
17373-1 |
More Info
|
ML-240 |
An ATP-competitive inhibitor of the D2 domain of the p97 ATPase (IC50 = 0.… |
10 mg |
17373-10 |
More Info
|
ML-240 |
An ATP-competitive inhibitor of the D2 domain of the p97 ATPase (IC50 = 0.… |
25 mg |
17373-25 |
More Info
|
ML-240 |
An ATP-competitive inhibitor of the D2 domain of the p97 ATPase (IC50 = 0.… |
5 mg |
17373-5 |
More Info
|
ML-243 |
An inhibitor of cancer stem cells, displaying 32-fold selective inhibition… |
1 mg |
15189-1 |
More Info
|
ML-243 |
An inhibitor of cancer stem cells, displaying 32-fold selective inhibition… |
10 mg |
15189-10 |
More Info
|
ML-243 |
An inhibitor of cancer stem cells, displaying 32-fold selective inhibition… |
25 mg |
15189-25 |
More Info
|
ML-243 |
An inhibitor of cancer stem cells, displaying 32-fold selective inhibition… |
5 mg |
15189-5 |
More Info
|
ML-261 |
A thienopyrrole-5-carboxamide; inhibits lipid droplet formation in murine… |
1 mg |
15192-1 |
More Info
|
ML-261 |
A thienopyrrole-5-carboxamide; inhibits lipid droplet formation in murine… |
10 mg |
15192-10 |
More Info
|
ML-261 |
A thienopyrrole-5-carboxamide; inhibits lipid droplet formation in murine… |
25 mg |
15192-25 |
More Info
|
ML-261 |
A thienopyrrole-5-carboxamide; inhibits lipid droplet formation in murine… |
5 mg |
15192-5 |
More Info
|
ML-262 |
An inhibitor of lipid droplet formation (IC50 = 6.4 nM in murine AML-12 ce… |
1 mg |
21902-1 |
More Info
|
ML-262 |
An inhibitor of lipid droplet formation (IC50 = 6.4 nM in murine AML-12 ce… |
10 mg |
21902-10 |
More Info
|
ML-262 |
An inhibitor of lipid droplet formation (IC50 = 6.4 nM in murine AML-12 ce… |
5 mg |
21902-5 |
More Info
|
ML-264 |
A selective inhibitor of KLF5 (IC50 = 29 nM in a cell-based assay for prol… |
1 mg |
18880-1 |
More Info
|
ML-264 |
A selective inhibitor of KLF5 (IC50 = 29 nM in a cell-based assay for prol… |
10 mg |
18880-10 |
More Info
|
ML-264 |
A selective inhibitor of KLF5 (IC50 = 29 nM in a cell-based assay for prol… |
25 mg |
18880-25 |
More Info
|
ML-264 |
A selective inhibitor of KLF5 (IC50 = 29 nM in a cell-based assay for prol… |
5 mg |
18880-5 |
More Info
|
ML-265 |
A selective activator of tumor-specific PKM2 (EC50 = 92 nM) that binds to… |
1 mg |
13942-1 |
More Info
|
ML-265 |
A selective activator of tumor-specific PKM2 (EC50 = 92 nM) that binds to… |
10 mg |
13942-10 |
More Info
|
ML-265 |
A selective activator of tumor-specific PKM2 (EC50 = 92 nM) that binds to… |
25 mg |
13942-25 |
More Info
|
ML-265 |
A selective activator of tumor-specific PKM2 (EC50 = 92 nM) that binds to… |
5 mg |
13942-5 |
More Info
|
ML-277 |
A potent activator of KCNQ1 (Kv7.1) channels (EC50 = 260 nM); EC50 > 30 &m… |
1 mg |
15193-1 |
More Info
|
ML-277 |
A potent activator of KCNQ1 (Kv7.1) channels (EC50 = 260 nM); EC50 > 30 &m… |
10 mg |
15193-10 |
More Info
|
ML-277 |
A potent activator of KCNQ1 (Kv7.1) channels (EC50 = 260 nM); EC50 > 30 &m… |
25 mg |
15193-25 |
More Info
|
ML-277 |
A potent activator of KCNQ1 (Kv7.1) channels (EC50 = 260 nM); EC50 > 30 &m… |
5 mg |
15193-5 |
More Info
|
ML-281 |
An inhibitor of STK33 (IC50 = 14 nM); has 700- and 550-fold selectivity fo… |
1 mg |
20116-1 |
More Info
|
ML-281 |
An inhibitor of STK33 (IC50 = 14 nM); has 700- and 550-fold selectivity fo… |
10 mg |
20116-10 |
More Info
|
ML-281 |
An inhibitor of STK33 (IC50 = 14 nM); has 700- and 550-fold selectivity fo… |
25 mg |
20116-25 |
More Info
|
ML-281 |
An inhibitor of STK33 (IC50 = 14 nM); has 700- and 550-fold selectivity fo… |
5 mg |
20116-5 |
More Info
|
ML-289 |
A negative allosteric modulator of mGlu3 (IC50 = 0.66 µM) that displ… |
1 mg |
15195-1 |
More Info
|
ML-289 |
A negative allosteric modulator of mGlu3 (IC50 = 0.66 µM) that displ… |
10 mg |
15195-10 |
More Info
|
ML-289 |
A negative allosteric modulator of mGlu3 (IC50 = 0.66 µM) that displ… |
25 mg |
15195-25 |
More Info
|